Author:
Schmidt Peter,Magnusson Caroline,Lundgren Torbjörn,Korsgren Olle,Nilsson Bo
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trial;PLOS ONE;2024-07-11
2. A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): an open-label, single-arm, single-centre, phase II trial;2023-08-29
3. Augmenting engraftment of beta cell replacement therapies for T1DM;Journal of Immunology and Regenerative Medicine;2021-12
4. Low Molecular Weight Dextran Sulfate (ILB®) Administration Restores Brain Energy Metabolism Following Severe Traumatic Brain Injury in the Rat;Antioxidants;2020-09-10
5. Regulation of c-Jun NH2-Terminal Kinase for Islet Transplantation;Journal of Clinical Medicine;2019-10-23